Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 1,436,425 | $143,628,164.00 | 7.92% |
Novo Nordisk AS, Class B | Equity | 642,004 | $66,405,578.00 | 3.66% |
ASML Holding NV | Equity | 60,899 | $45,979,540.00 | 2.54% |
AstraZeneca PLC | Equity | 335,312 | $45,160,952.00 | 2.49% |
TotalEnergies SE | Equity | 651,081 | $44,226,922.00 | 2.44% |
Safran SA | Equity | 247,117 | $43,592,504.00 | 2.4% |
SAP SE | Equity | 274,080 | $42,160,473.00 | 2.32% |
London Stock Exchange Group PLC | Equity | 352,520 | $41,672,714.00 | 2.3% |
Nestle SA | Equity | 302,922 | $35,059,397.00 | 1.93% |
Sika AG | Equity | 107,193 | $35,023,610.00 | 1.93% |
EssilorLuxottica SA | Equity | 145,753 | $29,295,734.00 | 1.62% |
L'Oreal SA, non-registered shares | Equity | 56,405 | $28,044,878.00 | 1.55% |
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) | Equity | 268,853 | $27,960,712.00 | 1.54% |
Keyence Corp. | Equity | 60,820 | $26,660,045.00 | 1.47% |
ABB, Ltd. | Equity | 591,945 | $26,305,496.00 | 1.45% |